Your browser doesn't support javascript.
Steroids in COVID-19: An overview.
Chatterjee, Kshitij; Wu, Chao-Ping; Bhardwaj, Abhishek; Siuba, Matthew.
  • Chatterjee K; Fellow, Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic chattek@ccf.org.
  • Wu CP; Fellow, Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic.
  • Bhardwaj A; Fellow, Department of Pulmonary Medicine, Respiratory Institute, Cleveland Clinic.
  • Siuba M; Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic.
Cleve Clin J Med ; 2020 Aug 20.
Article in English | MEDLINE | ID: covidwho-724168
ABSTRACT
Most antiviral or immunomodulatory therapies investigated for use in patients with COVID-19 have failed to show any mortality benefit. Similar to the previous pandemics caused by respiratory viruses, the role and benefit of corticosteroids has been under debate in COVID-19-related pulmonary disease. In this consult, we discuss the evidence regarding the efficacy of corticosteroid use in hospitalized patients with COVID-19, including data from the first randomized controlled trial on this subject.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Randomized controlled trials Language: English Journal subject: Medicine Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Randomized controlled trials Language: English Journal subject: Medicine Year: 2020 Document Type: Article